CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 115 enrolled
Drug / intervention
pREset thrombectomy retrieverdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02437409
NCT02437409N/ACompleted
CompareCT.gov

Acute Recanalization of Thrombo-Embolic Ischemic Stroke With pREset (ARTESp)

Phenox GmbH·observational·Posted May 7, 2015·Updated Aug 23, 2017

In Brief

An observational study evaluating pREset thrombectomy retriever for Stroke. Completed, enrolled 115 participants across 4 sites.

Detailed Summary

ARTESp is a prospective multicenter study in which the pREset thrombectomy system (phenox GmbH\* Germany) will be examined. The effectiveness, safety and the long-term success when using the pREset to treat acute occlusions of cerebral vessels will be analyzed. \*German: "Gesellschaft mit beschränkter Haftung", limited liability company

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsStroke
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMay 7, 2015
Enrollment StartFeb 1, 2013
Primary CompletionMar 1, 2015
Study CompletionAug 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 11.2 years ago

Interventions

pREset thrombectomy retrieverdevice

Interventional recanalization of acute cerebral vessel occlusions with the pREset thrombectomy system alone or in combination with intravenous or intraarterial thrombolytics (rt-PA).